Clean Boxing Program: Adrafinil

As part of the Clean Boxing Program implemented by the World Boxing Council (WBC), one of the substances that is strictly prohibited is Adrafinil, a compound that has generated controversy in different sports due to its effects.

Although not a stimulant itself, adrafinil is converted in the body to modafinil, and its use in sports has been monitored, because it provides an unnatural competitive advantage. The Clean Boxing Program, a joint initiative of the WBC and the Voluntary Anti-Doping Association (VADA), lists modafinil as a prohibited substance both in and out of competition. This automatically includes adrafinil on the blacklist, as it is its precursor.

In addition to altering performance, adrafinil carries cardiovascular and neurological risks, especially for high-performance athletes. Its use can elevate blood pressure, heart rate, and cause side effects such as anxiety, insomnia, or irritability. In boxing, where the body is pushed to its limits during training and combat, these alterations represent a real danger to an athlete’s integrity and well being.

The WBC has reiterated its commitment to health and sports ethics. The goal of the Clean Boxing Program, is not only to detect substances but also to promote a culture of prevention, education, and responsibility among boxers. The use of adrafinil or any other prohibited substance, can lead to sanctions, suspensions, and disqualification from fights, reaffirming the seriousness with which the fight against doping in professional boxing is taken.

To view the list of prohibited substances issued by VADA, you can consult the following link: https://wbcboxing.com/wp-content/uploads/2025/VADA-Prohibited-List-2025.pdf